HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jian Li Selected Research

Immune Checkpoint Inhibitors

1/2022Differential early diagnosis of benign versus malignant lung cancer using systematic pathway flux analysis of peripheral blood leukocytes.
1/2022Mutations of PI3K-AKT-mTOR pathway as predictors for immune cell infiltration and immunotherapy efficacy in dMMR/MSI-H gastric adenocarcinoma.
1/2022Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer.
1/2022Plasma extracellular vesicle derived protein profile predicting and monitoring immunotherapeutic outcomes of gastric cancer.
1/2022Impact of COVID-19 vaccination on the use of PD-1 inhibitor in treating patients with cancer: a real-world study.
1/2022Disruption of Wnt/β-catenin Pathway Elevates the Sensitivity of Gastric Cancer Cells to PD-1 Antibody.
1/2022PTCH1 mutation promotes antitumor immunity and the response to immune checkpoint inhibitors in colorectal cancer patients.
1/2022Three-Year Follow-Up of Neoadjuvant Programmed Cell Death Protein-1 Inhibitor (Sintilimab) in NSCLC.
1/2022Characteristics and Prognosis of Acquired Resistance to Immune Checkpoint Inhibitors in Gastrointestinal Cancer.
12/2021The Inconsistent and Inadequate Reporting Of Immune-Related Adverse Events in PD-1/PD-L1 Inhibitors: A Systematic Review of Randomized Controlled Clinical Trials.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jian Li Research Topics

Disease

532Neoplasms (Cancer)
12/2022 - 04/2002
226Infections
12/2022 - 10/2002
114Inflammation (Inflammations)
12/2022 - 12/2004
83Neoplasm Metastasis (Metastasis)
10/2022 - 01/2007
70Body Weight (Weight, Body)
04/2022 - 05/2003
60Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 04/2002
56Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2022 - 01/2009
56Breast Neoplasms (Breast Cancer)
01/2022 - 01/2007
51Hepatocellular Carcinoma (Hepatoma)
10/2022 - 11/2006
44Hypoxia (Hypoxemia)
07/2022 - 01/2002
39Carcinogenesis
01/2022 - 03/2011
37Pain (Aches)
07/2022 - 05/2005
37Fibrosis (Cirrhosis)
01/2022 - 09/2002
36Malaria
12/2022 - 01/2009
35Insulin Resistance
12/2021 - 12/2007
35POEMS Syndrome (Syndrome, POEMS)
11/2021 - 11/2010
34Lung Neoplasms (Lung Cancer)
10/2022 - 01/2008
34Carcinoma (Carcinomatosis)
04/2022 - 05/2006
33Type 2 Diabetes Mellitus (MODY)
10/2022 - 08/2008
31Alzheimer Disease (Alzheimer's Disease)
06/2022 - 05/2007
31Stomach Neoplasms (Stomach Cancer)
01/2022 - 09/2007
26Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2022 - 07/2010
25Wounds and Injuries (Trauma)
02/2021 - 06/2006
23Thalassemia
07/2022 - 10/2003
23Hypertension (High Blood Pressure)
06/2022 - 04/2011
23Hemorrhage
05/2022 - 12/2004
22Respiratory Tract Infections (Respiratory Tract Infection)
07/2022 - 10/2013
21Esophageal Squamous Cell Carcinoma
11/2022 - 06/2007
21Myocardial Infarction
02/2022 - 08/2003
21Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 03/2005
21Lymphoma (Lymphomas)
12/2021 - 01/2015
21Obesity
09/2021 - 09/2010
21Atrial Fibrillation
12/2020 - 08/2008
19COVID-19
06/2022 - 01/2020
18Thrombosis (Thrombus)
05/2022 - 02/2006
18Atherosclerosis
03/2022 - 09/2010
18Pneumonia (Pneumonitis)
03/2022 - 10/2007
18Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 01/2013
18Amyloidosis
01/2022 - 06/2011
18Critical Illness (Critically Ill)
12/2021 - 12/2007
18Multiple Myeloma
07/2021 - 10/2009
16Sepsis (Septicemia)
12/2022 - 03/2012
16Glioma (Gliomas)
07/2022 - 09/2012
16Esophageal Neoplasms (Esophageal Cancer)
06/2022 - 04/2000
16Disease Progression
01/2022 - 01/2010
16Lymphatic Metastasis
01/2022 - 12/2008
16Non-alcoholic Fatty Liver Disease
01/2022 - 03/2014
16Necrosis
12/2021 - 09/2007
15Heart Failure
11/2022 - 02/2008
15Immunoglobulin Light-chain Amyloidosis
07/2022 - 06/2015
15Prostatic Neoplasms (Prostate Cancer)
04/2022 - 02/2012

Drug/Important Bio-Agent (IBA)

176Proteins (Proteins, Gene)FDA Link
12/2022 - 07/2002
121Pharmaceutical PreparationsIBA
12/2022 - 11/2008
109Biomarkers (Surrogate Marker)IBA
10/2022 - 10/2005
87Colistin (Coly-Mycin)FDA Link
06/2022 - 05/2003
84MicroRNAs (MicroRNA)IBA
01/2022 - 11/2009
76Anti-Bacterial Agents (Antibiotics)IBA
10/2022 - 09/2006
69Messenger RNA (mRNA)IBA
07/2022 - 07/2005
64Biological ProductsIBA
06/2022 - 11/2004
56CytokinesIBA
01/2022 - 12/2004
49Polymyxins (Polymyxin)IBA
04/2022 - 09/2006
48Glucose (Dextrose)FDA LinkGeneric
01/2022 - 09/2006
42Polymyxin B (Aerosporin)FDA LinkGeneric
01/2022 - 12/2007
39DNA (Deoxyribonucleic Acid)IBA
01/2022 - 03/2003
37Long Noncoding RNAIBA
05/2022 - 01/2015
36Therapeutic UsesIBA
07/2022 - 08/2005
35Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2022 - 12/2003
31AntioxidantsIBA
08/2022 - 12/2007
30Immune Checkpoint InhibitorsIBA
01/2022 - 01/2019
29RNA (Ribonucleic Acid)IBA
01/2022 - 03/2003
28EnzymesIBA
03/2022 - 07/2005
28Cisplatin (Platino)FDA LinkGeneric
01/2022 - 03/2007
28VaccinesIBA
01/2022 - 04/2002
28Dexamethasone (Maxidex)FDA LinkGeneric
01/2022 - 10/2009
27AntigensIBA
01/2022 - 04/2002
25LipidsIBA
07/2022 - 05/2009
24Polysaccharides (Glycans)IBA
07/2022 - 09/2007
22Phosphotransferases (Kinase)IBA
11/2022 - 10/2005
22Peptides (Polypeptides)IBA
04/2022 - 04/2004
22Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 01/2014
21Indicators and Reagents (Reagents)IBA
08/2022 - 12/2008
21Transcription Factors (Transcription Factor)IBA
02/2022 - 01/2011
21Interleukin-6 (Interleukin 6)IBA
01/2022 - 10/2012
21Small Interfering RNA (siRNA)IBA
12/2021 - 09/2010
20LipopolysaccharidesIBA
12/2022 - 02/2011
20Tyrosine Kinase InhibitorsIBA
05/2022 - 10/2005
20Imatinib Mesylate (Gleevec)FDA Link
01/2022 - 03/2011
20Insulin (Novolin)FDA Link
12/2021 - 12/2007
19Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2022 - 09/2007
19ErbB Receptors (EGF Receptor)IBA
02/2022 - 01/2008
19LigandsIBA
02/2022 - 01/2014
17Bortezomib (Velcade)FDA Link
01/2022 - 10/2009
16Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 02/2006

Therapy/Procedure

300Therapeutics
12/2022 - 07/2004
109Drug Therapy (Chemotherapy)
06/2022 - 09/2003
30Radiotherapy
12/2021 - 09/2003
29Immunotherapy
01/2022 - 04/2010
19Aftercare (After-Treatment)
09/2022 - 05/2005
17Length of Stay
01/2022 - 11/2009
15Neoadjuvant Therapy
06/2022 - 07/2010